-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Methyl gallate
Category | Human immunodeficiency Virus (HIV) |
CAS | 99-24-1 |
Description | Methyl gallate isolated from the herbs of Sapium sebiferum. It is a reverse transcriptase inhibitor. |
Product Information
Synonyms | Methyl 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxy-benzoicacimethylester |
IUPAC Name | methyl 3,4,5-trihydroxybenzoate |
Molecular Weight | 184.15 |
Molecular Formula | C8H8O5 |
Canonical SMILES | COC(=O)C1=CC(=C(C(=C1)O)O)O |
InChI | InChI=1S/C8H8O5/c1-13-8(12)4-2-5(9)7(11)6(10)3-4/h2-3,9-11H,1H3 |
InChIKey | FBSFWRHWHYMIOG-UHFFFAOYSA-N |
Boiling Point | 450.1±40.0 °C at 760 mmHg |
Melting Point | 201-203 °C (lit.) |
Flash Point | 190.8±20.8 °C |
Purity | 0.98 |
Density | 1.5±0.1 g/cm3 |
Solubility | In vitro: 10 mM in DMSO |
Appearance | Powder |
Application | Used as an antioxidant. |
Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
Complexity | 181 |
Exact Mass | 184.03717335 |
Index Of Refraction | 1.631 |
In Vitro | The growth of A. viscosus is inhibited completely by a low dose of Methyl gallate (MIC=1 mg/mL). S. mutans and . sobrinus show intermediate sensitivity to Methyl gallate (MIC=2-4 mg/mL), whereas the growth of Lactobacillus spp. is inhibited completely at a relatively high concentration (MIC=8 mg/mL). Methyl gallate, in a concentration of 100 mM, could alleviate lipid peroxidation of the cells exposed to a short-term H2O2 treatment. In addition, Methyl gallate-treated cells could prevent intracellular glutathione (GSH) from being depleted following an exposure of H2O2 (8.0 mM) for a 3 h period. Methyl gallate inhibits Treg cell-suppressive effects on effector CD4+ T cells and Treg migration toward tumor environment. Furthermore, forkhead box P3 (Foxp3) expression is also significantly decreased by methyl gallate. |
PSA | 86.99000 |
Target | Bacterial; HIV; Reactive Oxygen Species |
Vapor Pressure | 0.0±1.1 mmHg at 25°C |
XLogP3-AA | 0.9 |